"Brachytherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
| Descriptor ID |
D001918
|
| MeSH Number(s) |
E02.815.150
|
| Concept/Terms |
Brachytherapy- Brachytherapy
- Radioisotope Brachytherapy
- Curietherapy
- Brachytherapy, Radioisotope
|
Below are MeSH descriptors whose meaning is more general than "Brachytherapy".
Below are MeSH descriptors whose meaning is more specific than "Brachytherapy".
This graph shows the total number of publications written about "Brachytherapy" by people in this website by year, and whether "Brachytherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 5 | 2 | 7 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 3 |
| 2024 | 5 | 0 | 5 |
| 2025 | 6 | 3 | 9 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brachytherapy" by people in Profiles.
-
Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Gynecol Oncol. 2019 02; 152(2):353-360.
-
Brachytherapy: where has it gone? J Clin Oncol. 2015 Mar 20; 33(9):980-2.
-
Design of an Yb-169 source optimized for gold nanoparticle-aided radiation therapy. Med Phys. 2014 Oct; 41(10):101709.
-
Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Am J Clin Oncol. 2014 Jun; 37(3):297-304.
-
Monte Carlo simulation to analyze the cost-benefit of radioactive seed localization versus wire localization for breast-conserving surgery in fee-for-service health care systems compared with accountable care organizations. AJR Am J Roentgenol. 2014 Jun; 202(6):1383-8.
-
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol. 2014 May 21; 59(10):2505-16.
-
Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy. Dis Colon Rectum. 2014 Apr; 57(4):442-8.
-
Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
-
Favourable long-term outcomes with brachytherapy-based regimens in men =60 years with clinically localized prostate cancer. BJU Int. 2013 Jun; 111(8):1231-6.
-
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1024-30.